SEC Comment Letter 0000000000-23-003999 to Better Therapeutics, Inc. (CIK 0001832415)
Better Therapeutics, Inc. (CIK 0001832415)
Date: April 20, 2023 · CIK: 0001832415 · Accession: 0000000000-23-003999
AI Filing Summary & Sentiment
File numbers found in text: 333-271302
Letter
United States securities and exchange commission logo April 20, 2023 Frank Karbe Chief Executive Officer Better Therapeutics, Inc. 548 Market Street, #49404 San Francisco, CA 94104
Re: Better Therapeutics, Inc. Registration Statement on Form S-3 Filed April 18, File No. 333-271302
Dear Frank Karbe:
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Benjamin Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
United States securities and exchange commission logo
April 20, 2023
Frank Karbe
Chief Executive Officer
Better Therapeutics, Inc.
548 Market Street, #49404
San Francisco, CA 94104
Re: Better
Therapeutics, Inc.
Registration
Statement on Form S-3
Filed April 18,
2023
File No. 333-271302
Dear Frank Karbe:
This is to advise you that we have not reviewed and will not
review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Benjamin
Richie at 202-551-7857 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Sam Zucker
</TEXT>
</DOCUMENT>